
There is little information available on the treatment of hot flashes in patients zzso to pharmaceutical zzso zzso evidence led to the use of zzso for the management of hot flashes in zzso cancer zzso therefore, we performed a retrospective chart review of such patients to determine the effect of zzso in treating hot flashes and to observe the side effects of the drug in these zzso 

A prospective database of all patients treated for hot flashes was started in July 2004 and was zzso analyzed as of March zzso Also included were individual charts preceding July zzso zzso patient charts were zzso zzso information was obtained along with baseline severity and frequency of hot zzso dose and duration of treatment with zzso patient response to zzso and side zzso 

More than zzso of patients analyzed were zzso to hot flash treatments before starting zzso zzso percent of patients showed a partial or excellent response to zzso The duration of zzso use ranged from 2 weeks to 5 years with more than half of patients currently on zzso or taking zzso for longer than 6 zzso Of those patients who experienced an excellent or partial response to treatment, zzso stopped because of documented zzso side effects within 4 zzso 

zzso seems promising in the management of hot flashes with tolerable side effects in the majority of zzso zzso A zzso zzso study is being developed to look more closely at the effectiveness of zzso in reducing hot zzso 

